We have been advised that fraudulent emails and faxes regarding unclaimed insurance money have been received by members of the public from a source claiming to be Aird & Berlis LLP. These communications are not from Aird & Berlis LLP. Disregard them and do not engage with the sender in any way. Please report the attempted fraud by contacting the Canadian Anti-Fraud Centre.

Back to all news
Jun 6, 2019
Firm News

Aird & McBurney | Aird & Berlis IP Professionals Recognized in IAM Patent 1000

Erica L. Lowthers, PhD, Kitt Sinden, M.Sc., Lola A. Bartoszewicz, PhD, Kimberly A. McManus, PhD, Timothy M. Lowman and L.E. Trent Horne

Aird & McBurney and Aird & Berlis are proud to be recognized in the Canada chapter of IAM Patent 1000 – The World's Leading Patent Professionals 2019.

Highlights from the editorial coverage include:

No technology is beyond the understanding of the accomplished team at Aird & Berlis LLP | Aird & McBurney LP, which has mastered the art of efficient patent registration.

The addition of Erica Lowthers and Kitt Sinden to the IAM Patent 1000 for 2019 means that the firm has four individuals recommended for prosecution, up from two in 2018. Pharmacology PhD Lowthers has “an excellent ability to evaluate patents and create fruitful development strategies. She knows how to generate IP value.” Sinden – who also has a pharmacology background – is not just a prosecutor but a business enabler.

Retaining their places in the guide are Lola Bartoszewicz and Kimberly McManus, who have PhDs in clinical biochemistry and chemistry respectively. As one respondent enthuses: “Lola understands what clients want and she delivers. She provides a first-rate service when it comes to biotech and pharmaceutical patents.” McManus serves on the Canadian Patent Agent Examining Board and possesses outstanding drafting and strategic advisory skills, making her an influential figure on the patent landscape. The firm has recently formed a cannabis industry group, central to which are Lowthers and McManus, who have lately been speaking at international conferences on how the drug’s legalisation intersects with intellectual property.

Litigants are also in safe hands with the firm, as they have Trent Horne and Timothy Lowman to turn to. Horne focuses on patent litigation and operates with confidence and poise whatever technology is in dispute. Lowman handles a broader spectrum of commercial and IP cases, which has honed his advocacy skills to a fine point.


About the IAM Patent 1000

The IAM Patent 1000 is a standalone publication that identifies individual and firm expertise in all major areas of patent law and practice. Through a research process conducted by a team of analysts, the publication identifies the top patent practitioners, as well as leading patent law and attorney firms, in 48 of the world’s most important jurisdictions and 18 U.S. states.


Related News

News Firm News
Denis Shapovalov Visits Aird & Berlis After Canada’s Historic Run in the Davis Cup Nov 29, 2019 Aird & Berlis is a proud sponsor of Denis Shapovalov, who achieved yet another significant career milestone this past weekend by making it to the Davis Cup Final in Madrid.
News Firm News
Aird & Berlis Opens the Market with Passport to Canada's Cannabis Sector Alliance Richard M. Kimel and Sherri M. Altshuler Nov 20, 2019 Aird & Berlis partners Sherri Altshuler and Richard Kimel joined forces with MNP LLP, MGO | ELLO and the Canadian Securities Exchange to open the market and to launch their “Passport to Canada Alliance.”
News Firm News
Ian Aversa Recognized as 2019 Lexpert Rising Star Nov 08, 2019 Aird & Berlis is proud to announce that partner Ian Aversa was recognized as a 2019 Lexpert Rising Star: Leading Lawyer Under 40.